CD68 and amyotrophic lateral sclerosis: Tissue-wide integrated intensity analyses revealed that microglial HLA-DR intensity remained unchanged in ALS (Fig. 1F), while CD68 and Iba1 intensities were significantly increased in both stage 1–3 ALS and stage 4 ALS compared with controls (Fig. 1G and H).